REUTERS/Brendan McDermid
"'Well how did you get to your 30% organic growth?'," athenahealth CEO Jonathan Bush said to a panel of laughing listeners. "I said I dunno. I got it out of my ass."
Einhorn has been publicly short athenahealth since May of 2014. In last week's presentation, he covered a wide range of topics - from monetary policy to European debt - but really dug into what's going on at the medical records company.
We've included that part of the slide deck here.
"At the Ira Sohn conference last year, we allowed relatively generous assumptions in the base case DCF, which valued athena at $50 per share," Einhorn said in closing. "Back then, we weren't forecasting a big slowdown in enterprise bookings, massive increases in capitalized research and development propping up the income statement, or Epic entering the cloud. As it stands now, we think athena's business performance is tracking closer to our bear case valuation of $14 per share. We continue to expect the athena stock bubble to pop."